Department of Pharmaceutical Sciences
April 18, 2017
UAMS’ Peter Crooks, Ph.D., D.Sc. Named Fellow of the National Academy of Inventors
April 18, 2017 | Peter Crooks, Ph.D., D.Sc., chair and professor of the Department of Pharmaceutical Sciences in the University of Arkansas for Medical Sciences (UAMS) College of Pharmacy, recently was named a Fellow of the National Academy of Inventors (NAI). Being named a Fellow recognizes NAI members who have, according to the academy, “demonstrated…
January 17, 2017
Study Shows Chemotherapy Induces Cellular Aging, Which Promotes Side Effects, Cancer Relapse
Jan. 17, 2017 | Chemotherapy for cancer causes a pro-inflammatory stress response that promotes adverse side effects and cancer relapse, says a research team that includes the University of Arkansas for Medical Sciences (UAMS). Daohong Zhou, M.D., associate director for basic research in the UAMS Winthrop P. Rockefeller Cancer Institute, is a co-author of the study…
September 1, 2016
Radiation Effects Expert Martin Hauer-Jensen Invested in J. Thomas May Distinguished Endowed Chair in Oncology
Sept. 1, 2016 | The family of the late William E. “Bill” Clark has given $300,000 to establish a distinguished endowed chair in honor of J. Thomas May in which world-renowned radiation effects expert Martin Hauer-Jensen, M.D., Ph.D., was invested Aug. 29 at the University of Arkansas for Medical Sciences (UAMS). Hauer-Jensen, a professor of…
August 12, 2015
UAMS Researchers Awarded $10.5 Million to Establish Center
UAMS researchers, led by Martin Hauer-Jensen, M.D., have secured a $10.5 million grant to establish a center to study side effects of cancer therapy.
UAMS Researchers Awarded $10.5 Million Grant to Establish Center for Study of Cancer-Therapy Toxicity
LITTLE ROCK – A team of UAMS researchers has secured a $10.5 million grant to establish a center to study side effects of of cancer therapy.